Cariprazine is an atypical antipsychotic, primarily used to treat schizophrenia and manic or mixed episodes associated with bipolar I disorder. As a dopamine D3/D2 and serotonin 5-HT1A receptor partial… Read more























![Chemical structure of Carbamic Acid,[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-, 1,1-dimethylethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F506427-91-4-Carbamic-Acidtrans-4-2-4-23-dichlorophenyl-1-piperazinylethylcyclohexyl-11-dimethylethyl-Ester.png&w=3840&q=75)
![Chemical structure of Carbamic acid, N-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-, ethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1957145-61-7-Carbamic-acid-N-trans-4-2-4-23-dichlorophenyl-1-piperazinylethylcyclohexyl-ethyl-Ester.png&w=3840&q=75)




















![Chemical structure of Ethyl trans-2-[4-(Boc-aMino)cyclohexyl]acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F946598-34-1-Ethyl-trans-2-4-Boc-aMinocyclohexylacetate.png&w=3840&q=75)


![Chemical structure of N'-[trans-4-[2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]-2-oxoethyl]cyclohexyl]-N,N-dimethylurea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2171074-48-7-N-trans-4-2-4-23-Dichlorophenyl-1-piperazinyl-2-oxoethylcyclohexyl-NN-dimethylurea.png&w=3840&q=75)

Cariprazine is an atypical antipsychotic, primarily used to treat schizophrenia and manic or mixed episodes associated with bipolar I disorder. As a dopamine D3/D2 and serotonin 5-HT1A receptor partial agonist, it helps modulate neurotransmitter activity in the brain. Laboratories rely on our comprehensive selection of Cariprazine reference standards to ensure the accuracy and reliability of their analytical processes. This collection includes high-quality impurities, metabolites, and stable isotope labelled compounds essential for rigorous impurity profiling, method validation, and routine quality control. These materials serve as critical benchmarks for identifying and quantifying process-related impurities and degradation products throughout the drug development lifecycle. By utilizing these precisely characterized reference standards, researchers can achieve the reproducible results required for regulatory compliance and the maintenance of product safety and efficacy in pharmaceutical analysis.